1. Parlette LE, Smith CK, Germain LM, Rolfe CA, Skelton H. Accelerated growth of dermatofibrosarcoma protuberans during pregnancy. J Am Acad Dermatol. 1999. 41:778–783.
2. Fiore M, Miceli R, Mussi C, Lo Vullo S, Mariani L, Lozza L, et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol. 2005. 23:7669–7675.
3. Gloster HM Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996. 35:355–374.
4. Hoffman E. Ueber alas knollentribende fibrosarkam der haut (dermatofibrosarcoma protuberans). Dermatol Z. 1925. 43:1–28.
5. Kim SH, Chang MC, Lee WA, Oh SK. Dermatofibrosarcoma protuberans in breast. J Korean Surg Soc. 2007. 72:63–65.
6. Haycox CL, Odland PB, Olbricht SM, Piepkorn M. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J Am Acad Dermatol. 1997. 37:438–444.
7. Handolias D, McArthur GA. Imatinib as effective therapy for dermatofibrosarcoma protuberans: proof of concept of the autocrine hypothesis for cancer. Future Oncol. 2008. 4:211–217.
8. Morrison AE, Lang PG. Case of rapidly enlarging dermatofibrosarcoma protuberans during pregnancy followed by metastasis in the absence of local recurrence. Dermatol Surg. 2006. 32:125–127.
9. Bigby SM, Oei P, Lambie NK, Symmans PJ. Dermatofibrosarcoma protuberans: report of a case with a variant ring chromosome and metastases following pregnancy. J Cutan Pathol. 2006. 33:383–388.
10. Abbott JJ, Oliveira AM, Nascimento AG. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Am J Surg Pathol. 2006. 30:436–443.